David A Schwartz Selected Research

Toll-Like Receptors (Toll-Like Receptor)

1/2016	Novel Innate Immune Genes Regulating the Macrophage Response to Gram Positive Bacteria.
10/2007	Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide.
9/2005	Toll-like receptor 4 mediates mitochondrial DNA damage and biogenic responses after heat-inactivated E. coli.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David A Schwartz Research Topics

Disease

34	Inflammation (Inflammations) 05/2019 - 01/2002
26	Crohn Disease (Crohn's Disease) 01/2022 - 01/2005
25	Asthma (Bronchial Asthma) 01/2022 - 04/2002
20	Idiopathic Pulmonary Fibrosis 01/2022 - 05/2002
18	Ulcerative Colitis 01/2022 - 07/2006
13	Fibrosis (Cirrhosis) 01/2022 - 12/2002
11	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2013
10	Lung Injury 01/2021 - 12/2003
10	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2020 - 07/2002
8	Infections 01/2022 - 08/2007
8	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 05/2002
8	Sepsis (Septicemia) 12/2018 - 12/2003
7	Fistula 01/2019 - 08/2005
7	Lung Diseases (Lung Disease) 12/2018 - 12/2002
7	Disease Progression 01/2016 - 01/2004
6	Neoplasms (Cancer) 01/2022 - 12/2002
6	Chronic Obstructive Pulmonary Disease (COPD) 12/2019 - 02/2005
6	Colitis 01/2019 - 01/2010
6	Respiratory Hypersensitivity 01/2016 - 07/2004
6	Airway Remodeling 07/2008 - 04/2002
5	Necrosis 01/2022 - 09/2002
5	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2022 - 10/2007
4	Hypoxia (Hypoxemia) 01/2022 - 03/2014
3	COVID-19 07/2022 - 07/2021
3	Pouchitis 01/2022 - 10/2007
3	Atherosclerosis 12/2019 - 07/2002
3	Abscess 01/2019 - 08/2005
3	Eosinophilia 01/2018 - 07/2003
3	Genetic Predisposition to Disease (Genetic Predisposition) 01/2015 - 02/2005
3	Pneumonia (Pneumonitis) 01/2010 - 01/2004
2	Rheumatoid Arthritis 01/2021 - 03/2008
2	Hyperplasia 12/2019 - 12/2003
2	Otitis Media 01/2019 - 11/2018
2	Cysts 12/2018 - 10/2016
2	Cystic Fibrosis (Mucoviscidosis) 12/2018 - 12/2006
2	Seasonal Allergic Rhinitis (Hay Fever) 04/2015 - 05/2008
2	Wounds and Injuries (Trauma) 12/2013 - 09/2010
2	Endotoxin Hyporesponsiveness 04/2005 - 09/2003

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 12/2020 - 04/2002
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2006
11	CytokinesIBA 05/2019 - 09/2002
10	EndotoxinsIBA 01/2013 - 04/2002
9	LipopolysaccharidesIBA 03/2014 - 04/2002
8	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2007
8	Surface-Active Agents (Surfactants)IBA 12/2018 - 05/2002
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2017 - 11/2006
7	AllergensIBA 09/2014 - 04/2002
7	Toll-Like Receptor 4IBA 01/2010 - 05/2002
6	MucinsIBA 01/2022 - 04/2011
6	Biological ProductsIBA 01/2019 - 04/2002
6	OzoneIBA 01/2016 - 04/2002
6	SmokeIBA 01/2015 - 04/2008
5	RNA (Ribonucleic Acid)IBA 08/2021 - 07/2015
5	AntigensIBA 04/2021 - 04/2002
5	Immunoglobulin E (IgE)IBA 07/2015 - 01/2002
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 05/2003
4	FibrinIBA 01/2022 - 09/2012
4	Certolizumab Pegol FDA Link 01/2018 - 03/2008
4	Messenger RNA (mRNA)IBA 10/2016 - 11/2008
4	Hyaluronic Acid (Hyaluronan)IBA 01/2016 - 11/2008
4	Methacholine Chloride (Methacholine)FDA Link 02/2015 - 11/2002
3	indium-bleomycinIBA 01/2021 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 07/2015
3	Protein CIBA 12/2018 - 05/2002
3	Adalimumab (Humira)FDA Link 01/2018 - 11/2006
3	Mucin-5BIBA 01/2017 - 01/2013
3	Arginine (L-Arginine)FDA Link 01/2016 - 01/2010
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2016 - 09/2005
3	Infliximab (Remicade)FDA Link 02/2014 - 08/2005
2	vedolizumabIBA 01/2022 - 01/2022
2	CollagenIBA 07/2021 - 01/2007
2	Pharmaceutical PreparationsIBA 01/2021 - 02/2014
2	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 12/2006
2	VaccinesIBA 01/2020 - 12/2018
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2019 - 01/2016
2	P-2 (P 2)IBA 12/2018 - 04/2011
2	Amino Acids FDA Link 01/2018 - 01/2016
2	Tumor Necrosis Factor InhibitorsIBA 01/2018 - 01/2016
2	Mesalamine (Mesalazine)FDA LinkGeneric 10/2017 - 01/2005
2	EnzymesIBA 01/2016 - 11/2006
2	Prednisone (Sone)FDA LinkGeneric 12/2015 - 08/2005
2	Azathioprine (Imuran)FDA LinkGeneric 12/2015 - 09/2014
2	Protease Inhibitors (Protease Inhibitor)IBA 10/2015 - 09/2007
2	Interleukin-4 (Interleukin 4)IBA 07/2015 - 07/2003
2	Interleukin-13IBA 07/2015 - 07/2003
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2014 - 01/2004
2	Matrix Metalloproteinases (MMPs)IBA 12/2013 - 11/2008
2	OvalbuminIBA 09/2010 - 07/2003
2	inter-alpha-inhibitorIBA 11/2008 - 09/2007
2	Complement System Proteins (Complement)IBA 09/2007 - 03/2007
2	Interleukin-10 (Interleukin 10)IBA 12/2006 - 11/2006
2	Oxygen (Dioxygen)IBA 09/2005 - 01/2005

Therapy/Procedure

35	Therapeutics 01/2022 - 07/2002
5	Restorative Proctocolectomy 01/2022 - 10/2007
3	Lung Transplantation 01/2019 - 09/2003
2	Colonic Pouches (S Pouch) 01/2022 - 04/2009
2	Operative Surgical Procedures 10/2021 - 09/2009
2	Precision Medicine 01/2021 - 12/2018
2	Aftercare (After-Treatment) 02/2015 - 11/2006
2	Blood Component Removal (Apheresis) 02/2008 - 07/2006